SWOG Early Exploration & Development (SEED) Fund supports SWOG investigators’ preliminary cancer research to inform future clinical trials and trial-associated translational studies.
Funder: Hope Foundation
Due Dates (Anticipated): July 2027 (Annual application deadline)
Funding Amounts: Up to $50,000 in direct costs; up to $62,500 including indirect costs over 1–2 years
Summary: Supports preliminary research by SWOG investigators that can lead to future SWOG and NCTN clinical trials or trial-associated translational studies.
Key Information: Applicants must be SWOG member investigators eligible for NIH funding; awards are administered through an institution.
The Hope Foundation’s SWOG Early Exploration & Development (SEED) Fund supports preliminary cancer research with potential to inform future clinical trials or trial-associated translational medicine studies within SWOG and the National Clinical Trials Network (NCTN). Supported work includes preclinical research, secondary analysis of clinical trial data, pilot and feasibility studies—including early-stage clinical trials—small self-contained projects, and development of research methods or technology.
The program seeks well-defined projects that can realistically be completed in one or two years. Direct application to larger future SWOG research is a central objective and measure of success. Another measure is investigators’ ability to secure extramural funding based on the supported work. Preliminary data are not required, particularly for pilot or feasibility studies; justification may come from literature, other data sources, or investigator-generated data.